Screening for hydroxychloroquine retinopathy. Screening should be selective.
作者信息
May K, Metcalf T, Gough A
出版信息
BMJ. 1998 Nov 14;317(7169):1388-9. doi: 10.1136/bmj.317.7169.1388a.
Abstract
摘要
相似文献
1
Screening for hydroxychloroquine retinopathy. Screening should be selective.羟氯喹视网膜病变的筛查。筛查应具有选择性。
BMJ. 1998 Nov 14;317(7169):1388-9. doi: 10.1136/bmj.317.7169.1388a.
2
Hydroxychloroquine retinopathy: is screening necessary?羟氯喹视网膜病变：是否需要筛查？
BMJ. 1998 Mar 7;316(7133):716-7. doi: 10.1136/bmj.316.7133.716.
3
Hydroxychloroquine retinopathy: screening needed to prevent blindness.
Med J Aust. 2011 Jan 3;194(1):55. doi: 10.5694/j.1326-5377.2011.tb04161.x.
4
Hydroxychloroquine retinopathy: screening needed to prevent blindness.
Med J Aust. 2010 Jun 7;192(11):668-9. doi: 10.5694/j.1326-5377.2010.tb03676.x.
5
The gathering storm: hydroxychloroquine retinopathy screening in the U.K.即将到来的风暴：英国的羟氯喹视网膜病变筛查
Br J Dermatol. 2017 Jun;176(6):1420-1421. doi: 10.1111/bjd.15567.
6
Clinical characteristics of hydroxychloroquine retinopathy.羟氯喹视网膜病变的临床特征。
Br J Ophthalmol. 2011 Feb;95(2):245-50. doi: 10.1136/bjo.2009.172148. Epub 2010 Aug 7.
7
Retinopathy after long term, standard doses of hydroxychloroquine.长期使用标准剂量羟氯喹后的视网膜病变。
Br J Ophthalmol. 1999 Oct;83(10):1201-2. doi: 10.1136/bjo.83.10.1194h.
8
We need to be better prepared for hydroxychloroquine retinopathy.我们需要对羟氯喹视网膜病变有更好的准备。
JAMA Ophthalmol. 2014 Dec;132(12):1460-1. doi: 10.1001/jamaophthalmol.2014.4090.
9
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.氯喹和羟氯喹视网膜病变筛查建议：美国眼科学会报告
Ophthalmology. 2002 Jul;109(7):1377-82. doi: 10.1016/s0161-6420(02)01168-5.
10
Ocular toxicity of hydroxychloroquine.羟氯喹的眼部毒性。
Semin Ophthalmol. 2008 May-Jun;23(3):201-9. doi: 10.1080/08820530802049962.
引用本文的文献
1
Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.10-2视野、多焦视网膜电图及频域光学相干断层扫描在检测羟氯喹和氯喹视网膜病变中的相对敏感性和特异性
Clin Ophthalmol. 2014 Jul 25;8:1389-99. doi: 10.2147/OPTH.S66527. eCollection 2014.
2
Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.氯喹和羟氯喹所致的眼毒性：电生理与视觉功能的相关性
Doc Ophthalmol. 2005 Jan;110(1):111-20. doi: 10.1007/s10633-005-7349-6.
3
Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.眼科问题。氯喹或羟氯喹视网膜病变。
Can Fam Physician. 2005 May;51(5):671, 679-80.
本文引用的文献
1
Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs.类风湿关节炎及相关疾病中的眼部病变，尤其涉及视网膜病变。对741例接受和未接受氯喹类药物治疗的患者的研究。
N Engl J Med. 1965 Aug 12;273(7):360-6. doi: 10.1056/nejm196508122730704.
2
Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine.
Eye (Lond). 1998;12 ( Pt 6):907-9. doi: 10.1038/eye.1998.236.
3
Hydroxychloroquine retinopathy: is screening necessary?羟氯喹视网膜病变：是否需要筛查？
BMJ. 1998 Mar 7;316(7133):716-7. doi: 10.1136/bmj.316.7133.716.
4
Prevalence of age-related maculopathy at two points in time in an elderly British population.英国老年人群中两个时间点年龄相关性黄斑病变的患病率。
Eye (Lond). 1997;11 ( Pt 3):301-14. doi: 10.1038/eye.1997.66.
5
Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.1207例患者在大型多中心门诊治疗中发生羟氯喹视网膜病变的发生率。
Arthritis Rheum. 1997 Aug;40(8):1482-6. doi: 10.1002/art.1780400817.
6
Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.羟氯喹毒性的眼科监测：现有数据的科学综述
Br J Rheumatol. 1997 May;36(5):599-601. doi: 10.1093/rheumatology/36.5.599.
7
Retinal toxicity in long term hydroxychloroquine treatment.长期使用羟氯喹治疗中的视网膜毒性
Ann Rheum Dis. 1996 Mar;55(3):187-9. doi: 10.1136/ard.55.3.187.
8
Ring maculopathies mimicking chloroquine retinopathy.酷似氯喹视网膜病变的环状黄斑病变
Am J Ophthalmol. 1974 Aug;78(2):204-10. doi: 10.1016/0002-9394(74)90077-4.
Zotero 插件